Iran Faces Medicine Shortages Amid War, Sanctions, Inflation

Iran is contending with a significant scarcity of essential medicines, a direct consequence of sustained geopolitical conflict, stringent international sanctions, and rising internal inflation. This confluence of factors has severely impacted the nation's ability to procure and distribute critical pharmaceutical supplies, leading to shortages across hundreds of medications.

## Catalyst Analysis: Deteriorating Supply Chains The current medicine scarcity in Iran stems from a multifaceted crisis. Prolonged conflict has disrupted infrastructure and trade routes, while international sanctions have limited Iran's access to global financial systems and key imports, including medical components and finished drugs. Simultaneously, domestic inflation erodes purchasing power and complicates the logistics of maintaining a stable pharmaceutical supply.

## Impact on Global Health & Geopolitical Risk ### Winners, Losers & Uncertainty The immediate losers are the Iranian populace, facing compromised healthcare access. From a broader perspective, the situation introduces uncertainty into regional stability, as humanitarian crises can exacerbate political tensions. There are no immediate clear winners in such a scenario, as the instability could create spillover effects.

### Risk Watch — Humanitarian & Economic Outlook This ongoing humanitarian challenge poses significant risks. The protracted unavailability of medicines could lead to public health crises, further destabilizing the nation and potentially impacting neighboring regions. Economically, the inability to import essential goods underscores the severe pressure on Iran's financial system and trade relationships, with no clear timeline for resolution under current geopolitical conditions.